Home » MingSight, Relin Form Joint Venture to Develop Diabetic Eye Disease Drug in China
MingSight, Relin Form Joint Venture to Develop Diabetic Eye Disease Drug in China
Shenzhen Relin Medicine and MingSight Pharmaceuticals have formed a joint venture, Jiangsu MingSight-Relin Pharmaceutical, to develop and commercialize MS-553 as an oral therapy for diabetic eye disease in China.
PBR
PBR
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May